MyFinsight
Home
About
Contact
vygr: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, VYGR has $288,311K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
288,311
322,101
Total stockholders' equity
219,825
243,944
Total liabilities and stockholders' equity
288,311
322,101
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$6,618K
Related party
collaboration receivable (see...
$851K
Accounts receivable
$3,186K
Marketable securities
$163,805K
Cash and cash
equivalents
$45,125K
Operating lease,
right-of-use assets
$29,740K
Marketable securities
$20,081K
Restricted cash
$5,614K
Property and equipment,
net
$13,291K
Total current assets
$219,585K
Total assets
$288,311K
Total liabilities and
stockholders' equity
$288,311K
Total stockholders'
equity
$219,825K
Total liabilities
$68,486K
Accumulated deficit
-$418,479K
Accumulated other
comprehensive income (loss)
$7K
Additional paid-in capital
$638,241K
Other non-current
liabilities
$1,000K
Deferred revenue, net of
current portion
$1,471K
Operating lease
liabilities, net of current...
$30,520K
Total current
liabilities
$35,495K
Common stock, 0.001 par
value 120,000,000...
$56K
Deferred revenue (see
note 8)
$10,578K
Operating lease
liabilities
$7,848K
Accrued expenses
$14,953K
Accounts payable
$2,116K
Buy me a coffee
Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. (VYGR)